• 제목/요약/키워드: Liquid flow measurement

검색결과 242건 처리시간 0.019초

개에서 피모벤단-펜톡시필린 분말 제형 합제의 경구투여시 약물약동학 및 약물약력학에 대한 연구 (Pharmacokinetics and Pharmacodynamics Following Oral Administration of Pimobendan-Pentoxifylline Powder Formulation Mixture in Dogs)

  • 노웅빈;송두원;강여림;박유진;유초롱;이종호;김기훈;정상희;강민희
    • 한국임상수의학회지
    • /
    • 제36권1호
    • /
    • pp.46-52
    • /
    • 2019
  • Pimobendan has inotropic and vasodilating effects on cardiovascular system, and pentoxifylline is known to decrease blood viscosity and improve blood flow to the heart. This study investigated the pharmacokinetics and pharmacodynamics following oral administration of pimobendan-pentoxifylline powder mixture in dogs. Eight healthy dogs were included and were divided into control (n = 4) and experimental (n = 4) groups. Vehicle powder and pimobendan-pentoxifylline powder mixture (pimobendane 0.25 mg/kg, pentoxifylline 15 mg/kg) were administrated orally to control and experimental groups, respectively. Plasma samples and measurement of echocardiographic indices were obtained for 24 hours following administration. Pimobendan and pentoxifylline concentrations were investigated using liquid chromatography-mass spectrometer (LC-MS) assay. The elimination half-life ($T_{1/2}$) were $2.65{\pm}1.42hours$ for pimobendan and $0.29{\pm}0.23hours$ for pentoxifylline. The time to reach maximum concentration ($T_{max}$) were $1.08{\pm}0.72hours$ for pimobendan and $0.29{\pm}0.14hours$ for pentoxifylline. The maximum blood concentration ($C_{max}$) were $2.83{\pm}1.50ng/mL$ for pimobendan and $1184.33{\pm}932.37ng/mL$ for pentoxifylline. Among echocardiographic indices, fractional shortening (FS), left ventricular internal diameter at end systole (LVIDs), and pre-ejection period (PEP) showed significant changes at 1-4 hours after the administration of pimobendan-pentoxifylline powder mixture. No adverse effects were observed during the investigation. This study demonstrates that pimobendan-pentoxifylline powder mixture can be used to control cardiovascular diseases in dogs.

이온쌍 역상 HPLC를 이용한 인체 말초혈액단핵구에서 이노신 5'-일인산 탈수소효소 활성의 정량적 측정 (Quantitative determination of inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells by ion-pair reversed-phase high-performance liquid chromatography)

  • 신혜진;권순호;박지명;권순효;이경률;김영진;이상후
    • 분석과학
    • /
    • 제23권6호
    • /
    • pp.531-536
    • /
    • 2010
  • 본 연구에서는 이온쌍 역상 HPLC/UV를 이용하여 건강한 한국인에서 분리된 말초혈액단핵구(PBMCs)에서 이노신 5'-일인산 탈수소효소(IMPDH)의 활성을 측정하였다. IMPDH는 이노신 5'-일인산(IMP)을 잔토신 5'-일인산(XMP)로 전환시키는 베타-니코틴아마이드 아데닌 디뉴클로티드 수화물(${\beta}-NAD^+$) 의존성 탈수소효소이며, 이것의 활성은 기질인 IMP와 조효소인 $NAD^+$의 존재 하에서 분해한 PBMCs로 부터 생성된 XMP에 해당하는 HPLC 크로마토그램을 정량적으로 분석함으로써 측정하였다. 생성된 XMP는 260 nm에서 검출하였다. 이동상으로는 7 mM tetra-n-butylammonium hydrogen sulfate가 포함된 37 mM potassium dihydrogen phosphate (pH 5.5)와 methanol의 혼합용액(85:15, v/v)을 사용하였으며, 유속은1 mL/min이었다. 정량 범위는 $0.2-50.0\;{\mu}M$이었으며, 이 때 정량 한계(LOQ)는 $0.2\;{\mu}M$이었다. 또한, 본 연구에서 확립된 시험법은 일내 정밀성(0.88-1.47%), 정확성(98.74-99.99%)과 일간 정밀성(0.85-5.24%), 정확성(99.95-101.65%)을 측정하여 검증하였다. 11명의 건강한 한국인에 대한 IMPDH 활성 측정 결과, 18.29-36.60 nmol/h/mg protein(평균값 $27.70{\pm}6.28\;nmol/h/mg$ protein)이었다.